Issue link: http://osercommunicationsgroup.uberflip.com/i/562613
C h a i n D r u g s t o r e D a i l y 7 7 M o n d a y, A u g u s t 2 4 , 2 0 1 5 superior product, but it takes a lot more than that to successfully launch and grow a brand. Our retail partners have been instrumental in our success, and we work very hard to live up to our promise that we will drive consumers to their shelves to purchase TriCalm. TriCalm has grown 276 percent as a brand over the last year, so clearly consumers have been respond- ing to our message. CDD: What do you think has been the most significant challenge you've faced thus far? JB: Probably overcoming all the chal- lenges that new brands face. It takes a lot to convince retailers to put you on the shelf, especially when you have no sales history. We lean very hard on the people we work with, and their experience. Our brokers have been fantastic in helping us convey the message that TriCalm is a worthy risk. David Biernbaum, our mas- ter broker, does more than anyone in the industry extolling the importance of new products to retailers. We're proud to be a success story that will hopefully create additional opportunities for new products and brands. CDD: Why should retailers carry TriCalm? JB: I spend a lot of my time answering that exact question. TriCalm solves itch in a completely new way, and it does so without the use of steroids. No other TriCalm (Cont'd. from p. 1) brand is growing faster in the anti-itch category, and that growth is still continu- ing. We have spent, and will continue to spend, aggressively to support the brand and drive consumers to the shelf looking for a safe and effective way to stop itch. Honestly, if it is a choice of yet another SKU from a legacy brand or TriCalm, I think the choice is pretty clear. CDD: What are your plans moving for- ward? JB: Our focus is to broaden our offering of products. TriCalm Hydrogel is a great product, and has proven to be a great OTC solution for acute itch. We have a host of new products that we feel treat other conditions associated with itch equally well. TriCalm Clinical Repair Cream is our answer for those who suf- fer from chronic itch, and is truly a dis- tinct product. We've devoted a lot of time and thought to our portfolio strate- gy, and we're excited to continue bring- ing differentiated new products to the market. We are committed to only bring- ing products that are proven to be supe- rior to what is currently available, and we believe we have a platform of tech- nology and innovation that allows us to do just that. For more information about TriCalm, contact Justin Brown at jbrown@cosmed- erm.com, call 858.550.7070 ext. 137 or visit www.tricalm.com. For sales informa- tion, contact David Biernbaum of David Biernbaum & Associates at david@ biernbaum.com, or call 314.434.6008. Tablets) 200mg is an oral antibacterial drug available only by prescription that is used in combination with other medi- cines to treat severe acne. Mayne Pharma Chief Executive Officer, Scott Richards, said, "We are pleased to have completed the acquisition of Doryx. The acquisition is extremely exciting for Mayne Pharma and will transform the business in terms of earn- ings and cash flow." The first step of establishing the U.S. Specialty Brands Division included the hiring of leadership and staff. New lead- ership talent was brought on board to drive and grow the new division, includ- ing the former Vice President of Warner Chilcott's U.S. Commercial Operations, Andy McClenaghan. Mayne Pharma recruited and trained a field sales team of more than 60 person- nel, many of whom have previous Doryx experience. This dedicated sales team has been in territory promoting the benefits of Doryx to dermatologists since mid-May. "The acquisition of Doryx and the establishment of the new U.S. Specialty Brands Division enable Mayne Pharma to now control the drug's entire value chain, from development, to manufac- ture, to distribution and on through mar- keting," Richards said. "We believe Doryx is differentiated from other prod- ucts in this category through its unique drug delivery formulation." Richards goes on to say, "The launch Mayne Pharma (Cont'd. from p. 1) of Doryx represents the first specialty brand product we have brought to market in the United States, and we expect to commercialize complementary product innovations over the coming years in der- matology and other specialty therapeutic areas utilizing the company's internal pipeline, targeted in-licensing and prod- uct acquisitions." Mayne Pharma is an ASX-listed spe- cialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally; either directly or through distri- bution partners, and also provides con- tract development and manufacturing services. A technology driven company, Mayne Pharma has a significant product portfolio and pipeline, global reach through distribution partners in Australia, the U.S., Europe and Asia. Mayne's two drug development and manufacturing facilities, based in Salisbury, Australia and Greenville, North Carolina, have expertise in formulating complex oral dose forms, including highly potent compounds, con- trolled substances, modified-release prod- ucts and inherently unstable compounds. Mayne Pharma has a 30-year track record of innovation and success in developing new oral drug delivery sys- tems, and these technologies have been successfully commercialized in numer- ous products that have been marketed around the world. Visit Mayne Pharma at booth #3316. Its fully integrated manufacturing net- work capabilities from API to finished formulation create a value chain that drives profitability and extends afford- ability to its customers. The company aspires to be the pre- ferred partner in delivering high quality products to the right markets and cus- tomers with the promise of better health. It is driven by the passion to excel in cre- ating healthy lives and happy stakehold- ers through outstanding product and service offerings. Citron focuses on bringing prod- ucts that revolutionize and change the way health and wellness are delivered. It strategizes and applies unique insights to deliver the right products to its customers. After all, when you col- laborate with the best, you deliver only the best. Citron aims to be a well recognized key player in marketing both brand and generic pharmaceuticals in the U.S. It Citron Pharma (Cont'd. from p. 1) seeks growth opportunities in specialty dosage forms and specialty therapeutic areas. The expertise behind Citron presents the company as a recognized marketing partner. It combines a passion for excel- lence with skillful proficiency to raise the performance standards and exceed expectations by bringing value and qual- ity to customers. Citron believes that quality is not just for its product line, but also for its sales and marketing programs that add value to its customers' bottom line. The company's flexible and cus- tomized marketing approach, along with its high-value product line enables it to be well prepared for any opportunities. Citron Pharma aims to be the most respected and valued business partner to all of its customers. Visit Citron Pharma at booth #2406. For more information, go to www.citron pharma.com or call 732.227.1515. SUCCESSFUL STRATEGIES TO SWEETEN SEASONAL SALES With seasonal candy representing 50 per- cent of drug channel confectionery sales, staying on-trend will make two holidays brighter for retailers. Celebrate each season by leveraging these key consumer insights: Easter has become a chocolate lover's tradition, with more than 60 per- cent of consumers celebrating Easter and 96 percent of Easter baskets including chocolate of some kind inside. M&M'S ® Brand is the number one brand for Easter baskets, candy bowls and egg hunts. Consumers will delight in the 2015 line- up, including M&M'S Brand Cane with bunny ears, DOVE ® Chocolate Solid Bunnies and MINIS MIX™ Chocolates in a stand up pouch. Retailers will attract impulse sales with the Mixed Singles Shapes Tower, which is double-sided and loaded with top-performing items. With Halloween and candy being almost synonymous with one another, understanding how to handle this seasonal product begins with utilizing variety packs, as they carve out 83 percent of sur- veyed consumers who find that variety bags make Halloween shopping easier. In 2014, Mars had five of the top 10 selling chocolate items, while continuing to invest in its variety bag portfolio. In addition to variety packs, Mars satisfies trick-or- treaters with FUN SIZE favorites such as SNICKERS, TWIX and M&M'S Brands. Attention-grabbing Halloween pack- aging will generate excitement on-shelf. Shoppers will howl with delight when they see their favorites renamed, as SNICKERS Xtreme becomes SNICK- ERS Xscream and 3 MUSKETEERS Bar transforms to 3 MuskeFEARS Bar with red nougat. M&M'S Brand is the most-pur- chased chocolate for Christmas baking, gifting, decorating, stuffing stockings and filling extra bowls, and according to some surveys, 90 percent of consumers partici- pate in Christmas with about half baking cookies and sweets and three-quarters of bakers using chocolate candies. New in 2015: SNICKERS Brand Baking Bites for the Holidays add a delightfully familiar flavor to holiday recipes. Shoppers will continue to buy seasonal favorites, like DOVE PROMIS- ES Peppermint Bark, as well as new twists to their favorite brands, like M&M'S Brand White Peppermint Candies for the Holidays and M&M'S Brand Mint Chocolate Candies Cane. Valentine's Day is known as the sea- son's go-to for chocolate consumption, with Valentine's Day chocolate pur- chasers spending an average of $23 on chocolate gifts for spouses and partners, children, grandchildren, friends and neighbors. M&M'S Brand is a top Valentine's Day treat, with shoppers showing their true love for M&M'S Chocolate Candies with purchases of colorful candy bowls and other gifts from the heart. Extra holiday tips that add to suc- cessful strategies begin with spotlighting the season with secondary displays in high traffic areas. Mars makes it easy with eye-catching displays, from ship- pers with the new Mixed Shapes & Singles Tower, which retailers can stand, hang or mount to capture impulse buys. Amp up seasonal excitement with vibrant seasonal packaging from Mars that adds excitement to the seasonal aisle, attracts attention to stand out on-shelf, and is an important cue to connect with the shopper. Take advantage of the fact that shop- pers gobble up seasonal shapes, so be sure to stock up on the most popular, including TWIX Ghosts and Santas, SNICKERS Pumpkins and Trees, and MILKY WAY Simply Caramel Snowmen. From traditional holiday favorites to innovative new flavors, Mars has the drug channel's seasonal success in the bag! For more information, go to www.mars.com or call 800.631.7630.